{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-006963","form_type":"8-K","ticker":null,"cik":"0001567892","company_name":"Keenova Therapeutics plc","filed_at":"2024-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.646188+00:00","generated_at":"2026-06-06T16:33:56.668319+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mallinckrodt extends CEO Siggi Olafsson's tenure 30 days through Feb 28 amid contract talks","bullets":["CEO Olafsson had given notice of resignation effective Jan 29, 2024; agreed to stay through Feb 28, 2024.","Extension includes $123,750 cash payment (target bonus for period) plus severance upon termination.","Company is negotiating new employment agreement; no assurance Olafsson will remain beyond Feb 28.","Reimbursement of legal/tax advisory fees for negotiations, subject to release if no new agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-006963","json":"https://secwatch.observer/filing/0001104659-24-006963.json","markdown":"https://secwatch.observer/filing/0001104659-24-006963.md","text":"https://secwatch.observer/filing/0001104659-24-006963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567892/000110465924006963/0001104659-24-006963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567892/000110465924006963/tm244193d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T16:33:56.668319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0238e87b97","claim":"Sigurdur (Siggi) Olafsson resigned as President and Chief Executive Officer at Keenova Therapeutics plc.","evidence_excerpt":"Mr. Olafsson had previously provided written notice of his intention to resign as an employee effective January 29, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465924006963/0001104659-24-006963-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}